561 Shares in McKesson Co. (NYSE:MCK) Acquired by Stevens Capital Management LP

Stevens Capital Management LP acquired a new position in McKesson Co. (NYSE:MCK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 561 shares of the company's stock, valued at approximately $320,000.

A number of other large investors also recently bought and sold shares of the business. Millstone Evans Group LLC purchased a new stake in McKesson during the fourth quarter valued at approximately $28,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of McKesson during the 3rd quarter valued at $31,000. Synergy Asset Management LLC purchased a new position in McKesson during the 4th quarter worth $32,000. Crews Bank & Trust purchased a new stake in McKesson in the fourth quarter valued at about $33,000. Finally, Atala Financial Inc purchased a new stake in shares of McKesson during the fourth quarter worth about $34,000. Institutional investors own 85.07% of the company's stock.

McKesson Stock Performance

Shares of NYSE:MCK traded up $4.07 during midday trading on Thursday, reaching $667.09. 152,095 shares of the company's stock traded hands, compared to its average volume of 819,069. The company has a market cap of $83.60 billion, a P/E ratio of 30.54, a PEG ratio of 1.29 and a beta of 0.52. The company has a fifty day simple moving average of $620.63 and a two-hundred day simple moving average of $577.10. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $670.79.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. As a group, research analysts forecast that McKesson Co. will post 32.77 EPS for the current fiscal year.

Remove Ads

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be given a $0.71 dividend. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.43%. McKesson's dividend payout ratio (DPR) is presently 13.00%.

Insider Buying and Selling

In other news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $600.66, for a total value of $5,382,514.26. Following the completion of the sale, the chief executive officer now directly owns 69,625 shares in the company, valued at $41,820,952.50. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Leann B. Smith sold 579 shares of the business's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now owns 864 shares in the company, valued at $494,890.56. The trade was a 40.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,689 shares of company stock worth $11,187,351. 0.11% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on MCK shares. Evercore ISI increased their price objective on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research report on Thursday, February 6th. StockNews.com downgraded McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Bank of America lowered their price target on McKesson from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Citigroup cut their price objective on shares of McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Finally, Mizuho initiated coverage on shares of McKesson in a report on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, McKesson presently has a consensus rating of "Moderate Buy" and an average target price of $649.36.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.